Piramal Pharma Shows Positive Short-Term Momentum Amid Medium-Term Volatility
Piramal Pharma experienced a notable increase on January 20, 2025, outperforming its sector. The stock reached an intraday high, indicating a positive trend in the short to long term, although it showed some volatility in the medium term. Its recent performance surpassed the Sensex, despite a decline over the past month.
Piramal Pharma, a key player in the pharmaceuticals and drugs sector, saw a significant increase of 4.05% on January 20, 2025, outperforming its sector by 4.04%. The stock reached an intraday high of Rs 241.5, reflecting a rise of 4.66% during the trading session.In terms of moving averages, Piramal Pharma is currently above the 5-day, 100-day, and 200-day moving averages, indicating a positive trend in the short to long term. However, it remains below the 20-day and 50-day moving averages, suggesting some volatility in the medium term.
Over the past day, the stock's performance was recorded at 3.66%, significantly outperforming the Sensex, which increased by 0.70%. However, the company's performance over the past month has been less favorable, with a decline of 5.30%, compared to the Sensex's decrease of 1.13%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
